ID: ALA5316202

Max Phase: Preclinical

Molecular Formula: C61H86N10O9

Molecular Weight: 1103.42

Associated Items:

Representations

Canonical SMILES:  CC(C)C[C@@H](/C=C/[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=O)OCc1ccccc1)C(=O)NCCCCCC1(c2nc3c(C(N)=O)cccc3[nH]2)CCCN1)C(C)C)NC(=O)OC(C)(C)C

Standard InChI:  InChI=1S/C61H86N10O9/c1-40(2)37-45(66-59(78)80-60(5,6)7)30-29-44(38-42-21-11-8-12-22-42)56(76)71-36-19-28-49(71)54(74)69-50(41(3)4)55(75)67-48(27-18-34-64-58(77)79-39-43-23-13-9-14-24-43)53(73)63-33-16-10-15-31-61(32-20-35-65-61)57-68-47-26-17-25-46(52(62)72)51(47)70-57/h8-9,11-14,17,21-26,29-30,40-41,44-45,48-50,65H,10,15-16,18-20,27-28,31-39H2,1-7H3,(H2,62,72)(H,63,73)(H,64,77)(H,66,78)(H,67,75)(H,68,70)(H,69,74)/b30-29+/t44-,45-,48+,49+,50+,61?/m1/s1

Standard InChI Key:  HGCPBYQTJFPZGA-UGFLPWHZSA-N

Associated Targets(Human)

Poly [ADP-ribose] polymerase-1 6206 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 1103.42Molecular Weight (Monoisotopic): 1102.6579AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Borgini M, Wipf P..  (2023)  Synthesis of Veliparib Prodrugs and Determination of Drug-Release-Dependent PARP-1 Inhibition.,  14  (5): [PMID:37197461] [10.1021/acsmedchemlett.3c00065]

Source